• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 443085 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1419038628 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1419038628 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Shares of Masimo Are Moving Lower on 1.9x Above-Average Volume (MASI)

Published on Fri, 02/15/2013 - 14:11
By Robert Cotter

Shares of Masimo are trading today in above average volume, with the share price falling 1.2% to $19.99. About 793,000 shares have been traded today, as compared to the 30-day average volume of 428,000 shares. Spikes in volume can validate a breakout or signify a potential turning point.

There is potential upside of 36.7% for shares of Masimo based on a current price of $19.99 and an average consensus analyst price target of $27.33. Masimo shares should first meet resistance at the 50-day moving average (MA) of $20.53 and find additional resistance at the 200-day MA of $21.51.

In the past 52 weeks, shares of Masimo have traded between a low of $17.62 and a high of $35.15 and are now at $19.99, which is 13% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.2% while the 200-day MA has slid 0.2%.

Masimo Corporation designs, develops and licenses medical signal processing and sensor technology for the noninvasive monitoring of physiological parameters. The Company's first products are designed to improve the effectiveness of pulse oximetry by overcoming the inability of current monitors to precisely measure the levels of arterial blood oxygen saturation and low arterial blood flow.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Shares of Wells Fargo Rise to a New 52-W...

Wells Fargo (NYSE:WFC) traded at a new 52-week high today of $55.42. Approximately 20. ...

Watch for Continued Gains in Shares of W...

Wisconsin Energy (NYSE:WEC) traded today at a new 52-week high of $52.50. So far today ...

Recent 52-Week High Exceeded in Shares o...

Shares of Western Digital (NYSE:WDC) traded today at $114.69, breaking its 52-week high ...

WellCare Health Plans: The Winning Strea...

Shares of WellCare Health Plans (NYSE:WCG) traded at a new 52-week high today of $80.95 ...

Vertex Pharmaceuticals Looks to Continue...

Vertex Pharmaceuticals (NASDAQ:VRTX) traded at a new 52-week high today of $123.82. Th ...

Shares of Vornado Realty Trust Rise Abov...

Shares of Vornado Realty Trust (NYSE:VNO) traded today at $117.37, breaking its 52-week ...

US Bancorp Looks to Continue to Trade Ab...

Shares of US Bancorp (NYSE:USB) traded today at $45.54, breaking its 52-week high. So ...

United Parcel Service Looks to Continue ...

United Parcel Service (NYSE:UPS) traded today at a new 52-week high of $111.99. So far ...